juvederm vs restylane

When patients sit down for a filler consultation, the question I hear most often is not “what do I need?” — it is “which brand is better?” Juvederm and Restylane are the two dominant hyaluronic acid filler families in the United States, and both are backed by decades of clinical data. But they are not interchangeable. Understanding where each brand excels — and where it falls short — helps me recommend the right product for each face and goal, and it helps medspa owners train their teams to have honest, confident conversations at the treatment chair.

This guide walks through every meaningful difference between the two families, the specific products within each line that matter most, real cost ranges, and the patient profiles where each brand tends to win.

Side-by-Side Specification Table

Understanding the Formulation Difference

The most important technical distinction is how the hyaluronic acid is cross-linked. Juvederm uses either HYLACROSS (older products like Juvederm Ultra) or Vycross technology (newer products like Juvederm Voluma, Volbella, Vollure). Vycross blends high- and low-molecular-weight HA chains, which produces a firmer gel with longer duration and lower swelling. NASHA technology in classic Restylane products creates a more particulate gel with a distinct feel under the skin.

Restylane’s newer OBT (Optimal Balance Technology) products — including Restylane Lyft and Restylane Contour — aim to combine lift capacity with tissue integration. The practical result is a product that behaves more cohesively and tracks movement more naturally, which matters in high-motion areas like the cheeks.

Juvederm Product Line Breakdown

• Juvederm Ultra XC / Ultra Plus XC: Classic workhorses for lips and nasolabial folds. Softer gel, ideal for lips. Duration est. 6–12 months in lips, up to 18 months in folds.
• Juvederm Voluma XC: Vycross formulation designed for mid-face volume and cheek lift. FDA-approved for up to 2 years. Firmer, more lifting than the Ultra line.
• Juvederm Vollure XC: Mid-range firmness, ideal for moderate-to-severe nasolabial folds. FDA-approved for up to 18 months. Good tissue integration.
• Juvederm Volbella XC: Ultra-fine Vycross product for lip definition and perioral lines. Minimal swelling, est. 12-month duration in lips.

Restylane Product Line Breakdown

• Restylane-L: Classic NASHA gel for moderate wrinkles and lip augmentation. Est. 6–12 month duration depending on area and metabolism.
• Restylane Lyft: Higher G’ (firmness), approved for cheek augmentation and midface correction. Also FDA-approved for hands. Comparable to Voluma in lift capacity.
• Restylane Silk: Fine-particle product for lip definition and perioral lines. Very soft, precise placement. Direct competitor to Volbella.
• Restylane Defyne / Refyne: OBT products that flex with facial expressions. Defyne for deeper folds, Refyne for more moderate correction. Excellent for smile lines and marionette lines.
• Restylane Contour: Newest mid-face product with lateral cheek sculpting capability. Moves naturally with facial animation.
• Restylane Kysse: OBT lip filler with high flexibility, designed to move with lip motion. Longer duration in lips than Restylane-L.

Pros and Cons: Juvederm

Pros

• Smoother gel texture makes it forgiving in lips and soft tissue areas.
• Voluma has among the longest FDA-approved durations of any HA filler — up to 2 years.
• Allergan brand recognition — many patients ask for it by name.
• Consistent product availability through well-established US distribution.
• ASPIRE rewards program offers patient loyalty points that can reduce repeat cost.

Cons

• Vycross products can swell more than alternatives in the first 48 hours.
• Smoother gel can migrate slightly if over-injected in fine areas.
• Premium pricing at most distributors relative to Restylane equivalents.
• Fewer options for dynamic expression areas compared to Restylane’s OBT line.

Pros and Cons: Restylane

Pros

• OBT technology (Defyne, Refyne, Kysse, Contour) tracks natural movement better in high-animation areas.
• Restylane Kysse is currently one of the best-studied lip fillers for natural movement.
• Restylane Lyft is approved for both face and hands — versatility for treatment planning.
• Slightly firmer gel in non-OBT products gives more predictable structural lift.
• ASPIRE Galderma rewards program — competitive with Allergan’s offering.

Cons

• Particulate texture requires more injector skill to avoid lumps in fine areas.
• Classic NASHA products can feel firmer under skin — noticeable in very superficial placement.
• Shorter FDA-approved duration for cheek products versus Juvederm Voluma.
• Larger product library creates complexity — patients and less experienced injectors can be confused by the options.

Which Filler Wins for Each Treatment Area?

Lips

Both brands have competitive lip products. I favor Juvederm Ultra XC or Volbella for patients who want a softer, more subtle result with minimal swelling. Restylane Kysse tends to perform better for patients who want a natural lip that moves expressively — the OBT technology is a genuine advantage here. For injectors early in their career, Juvederm’s smooth gel is more forgiving.

Cheeks and Mid-Face

This is the closest contest. Juvederm Voluma has the edge in FDA-approved duration. Restylane Contour has the edge in lateral movement and animation. For significant structural lift in a single session, Voluma is my preference. For patients who move their face extensively and worry about a static appearance, Contour or Lyft may serve them better.

Under-Eyes (Tear Troughs)

Restylane-L or Restylane Silk wins this area for me. The firmer, more particulate gel is less prone to the Tyndall effect (blue discoloration from superficial placement) when placed carefully. Juvederm’s smoother gel can spread slightly under the thin periorbital skin, increasing that risk. This is an injector-dependent area and technique matters more than brand, but if I had to choose one family for under-eyes, I choose Restylane.

Nasolabial Folds and Marionette Lines

Restylane Defyne and Juvederm Vollure are direct competitors in this area. Both perform well. Defyne tracks animation better; Vollure has a slightly longer approved duration. For patients with deep, static folds, Vollure often provides more visible correction per syringe.

Jawline Definition

Both Restylane Lyft and Juvederm Voluma are used off-label for jawline augmentation. Both work. Lyft’s cohesive gel tends to stay where it is placed without spreading, which is an advantage along a structural bony landmark like the jaw.

Common Mistakes When Choosing Between These Fillers

• Choosing by brand loyalty instead of tissue need: The brand is secondary to the G’ (firmness) and rheological properties of the specific product. Match the product to the depth and tissue type, not the logo.
• Defaulting to the same product for every area: Patients who want lips and cheeks treated in the same session often benefit from two different products, not one filler used everywhere.
• Ignoring patient movement patterns: Active patients who talk and smile constantly need OBT products in dynamic areas. A static gel that looks great at rest can look unnatural in motion.
• Underestimating swelling timelines: Juvederm Vycross products can swell more in the first 48–72 hours before settling. Patients who judge their results immediately and complain of over-filling may simply need more time.
• Not stocking both product families: Medspas that carry only one brand limit their ability to optimize outcomes. Both families have products where they excel.

How Longevity Differs Between the Two Brands

Duration is one of the most frequently misunderstood aspects of filler counseling. Patients often hear “it lasts a year” and take that as a hard guarantee. In reality, filler longevity varies based on the area treated, the specific product used, the patient’s metabolic rate, the volume injected, and how much movement the area experiences daily.

Hyaluronic acid is naturally present in the body and is gradually broken down by hyaluronidase — an enzyme the body produces. Highly mobile areas like lips break down filler faster than structurally stable areas like the cheekbones. A patient who chews gum constantly, talks animatedly, and has a fast metabolism will metabolize both Juvederm and Restylane faster than a patient with the opposite profile.

The longest published duration data belongs to Juvederm Voluma — up to 2 years in the mid-face per its FDA approval. This stands above the typical 12–18 month range for most other HA fillers. For patients who want maximum duration before retreatment, Voluma in the cheeks represents the best value on a per-month basis despite its higher per-syringe cost.

For lips, which move constantly and metabolize filler fastest, most patients in my experience return at 6–12 months for both Juvederm Ultra and Restylane Kysse. The OBT technology in Kysse does not appear to meaningfully extend duration relative to other lip products — its advantage is in movement quality, not longevity.

How to Present Filler Choices to Patients During Consultation

The consultation is where the filler choice is made, and it is also where patient confidence is built or lost. I coach medspa teams to avoid asking patients “do you want Juvederm or Restylane?” — most patients have no meaningful basis for that answer, and the question creates false decision pressure.

A better consultation structure is to identify the area first, describe the goal in patient language (softer lips, fuller cheeks, less tired-looking under-eyes), then explain that you will recommend a specific product from whichever family is best suited. Patients want the outcome, not the brand. Presenting yourself as the expert who selects the right tool builds more trust than offering a menu of equally valid options.

Where brand conversation adds value is in setting timeline expectations — “this is a Vycross product, so you may see more swelling in the first 48 hours before it settles” — and in loyalty program enrollment, which most practices underutilize.

Pricing Strategy for Medspa Owners

Both product families are priced similarly to patients — est. $650–$950 per syringe in most markets. Where the margin varies is your acquisition cost. Allergan and Galderma both offer tiered pricing based on purchase volume, and loyalty programs like Allē and ASPIRE Galderma can reduce your effective per-unit cost significantly. If your practice volume justifies it, enrolling in both programs and tracking redemptions quarterly can reduce product costs by est. 10–20 percent.

Run your treatment profitability numbers — including product cost, injector time, and overhead — through our medspa revenue calculator to see where each filler line sits on your margin stack. If you want to see how your current filler marketing compares to top-performing medspa positioning, the medspa marketing hub has the benchmarks you need.

Ready to sharpen how you present filler options to patients and convert more consultations? Book a free strategy call and I’ll give you a direct read on your treatment menu and conversion process.